Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseasesWagner, Karen M.; McReynolds, Cindy B.; Schmidt, William K.; Hammock, Bruce D. · Pharmacology & Therapeutics · 2017

Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular NeovascularizationSulaiman, Rania S.; Park, Bomina; Sheik Pran Babu, Sardar Pasha; Si, Yubing; Kharwadkar, Rakshin; Mitter, Sayak K.; Lee, Bit; Sun, Wei; Qi, Xiaoping; Boulton, Michael E.; Meroueh, Samy O.; Fei, Xiang; Seo, Seung-Yong; Corson, Timothy W. · ACS Chemical Biology · 2017

A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty ratHye Khan, Md. Abdul; Hwang, Sung Hee; Sharma, Amit; Corbett, John A.; Hammock, Bruce D.; Imig, John D. · Prostaglandins & Other Lipid Mediators · 2016

Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto–Kakizaki ratsOlearczyk, Jeffrey J.; Quigley, Jeffrey E.; Mitchell, Bradford C.; Yamamoto, Tatsuo; Kim, In-Hae; Newman, John W.; Luria, Ayala; Hammock, Bruce D.; Imig, John D. · Clinical Science · 2009

Anti-inflammatory Effects of ω-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II–Dependent HypertensionUlu, Arzu; Harris, Todd R.; Morisseau, Christophe; Miyabe, Christina; Inoue, Hiromi; Schuster, Gertrud; Dong, Hua; Iosif, Ana-Maria; Liu, Jun-Yan; Weiss, Robert H.; Chiamvimonvat, Nipavan; Imig, John D.; Hammock, Bruce D. · Journal of Cardiovascular Pharmacology · 2013